Zusammenfassung
Die Basisdiagnostik (s. auch Tabelle 7.1) bei gesicherter arterieller Hypertonie (Gelegenheitsblutdruckmessung, ambulante Blutdruckselbstmessung, ambulante Blutdrucklangzeitmessung; s. Kapitel 6) besteht aus
-
Anamnese (Familienanamnese, Eigenanamnese, Berufsanamnese),
-
körperlicher Untersuchung,
-
Erhebung laborchemischer Parameter und
-
weiterführenden Untersuchungen wie Sonografie, EKG, ev. Belastungs-EKG, Echokardiografie und spezieller Ultraschalluntersuchung der A. carotis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Arnett DK, Rautaharju P, Crow R, Folsom AR, Ekelund LG, Hutchinson R, Tyroler HA, Heiss G (1994) Black-white differences in electrocardiographic left ventricular mass and its association with blood pressure (the ARIC Study). Am J Cardiol 74:247–252
Bixler EO, Vgontzas AN, Lin H-M, Have TT, Leiby BE, Vela-Bueno A, Kales A (2000) Association of hypertension and sleep-disordered breathing. Arch Intern Med 160:2289–2295
Bostom AG, Selhub J (1999) Homocysteine and arteriosclerosis. Subclinical and clinical disease associations. Circulation 99:2361–2363
Cooper WD, Glover DR, Hormbrey JM, Kimber GR (1989) Headache and blood pressure: evidence of a close relationship. J Hum Hypertens 3:41–44
De Simone G (1999) Guidelines for arterial hypertension: the echocardiography controversy. J Hypertension 17:735–736
Deutsche Liga zur Bekämpfung des hohen Blutdruckes e.V. (2001) Deutsche Hypertonie Gesellschaft. Empfehlungen zur Hochdruckbehandlung. Merkblatt, 16. Auflage, Heidelberg
Devereux RB, Okin PM, Roman MJ (1999) Left ventricular hypertrophy as a surrogate endpoint in hypertension. Clin Exper Hypertension 21(5, 6):583–593
Devereux RB, Pini R, Aurigemma GP, Roman MJ (1997) Measurement of left ventricular mass: methodology and expertise. J Hypertension 15:801–809
Fang J, Alderman MH (2000) Serum uric acid and cardiovascular mortality. The NHANES I epidemiologic follow-up study, 1971-1992. JAMA 283:2404–2410
Ferrannini E, Mari A (1998) How to measure insulin sensitivity. J Hypertension 16:895–906
Gerstein HC (1999) Is glucose a continuous risk factor for cardiovascular mortality? Diabetes Care 22:659–660
Guidelines Sub-Committee (1999) World Health Organisation-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertension 17:151–183
Hankey GJ, Eikelboom JW (1999) Homocysteine and vascular disease. Lancet 354:407–413
Julius S, Valentini M, Palatini P (2000) Overweight and hypertension. Hypertension 35:807–813
Liao D, Arnett DK, Tyroler HA, Riley WA, Chambless LE, Szklo M, Heiss G (1999) Arterial stiffness and the development of hypertension. The ARIC study. Hypertension 34:201–206
McGregor E, Isles CG, Jay JL, Lever AF, Murray GD (1986) Retinal changes in malignant hypertension. Br Med J 292:233–234
Okin PM, Roman MJ, Devereux RB, Pickering TG, Borer JS, Kligfield P (1998) Time-voltage QRS area of the 12-lead electrocardiogram. Detection of left ventricular hypertrophy. Hypertension 31:937–942
O’Rourke MF, Mancia G (1999) Arterial stiffness. J Hypertension 17:1–4
Patel V, Kohner EM (1994) The eye in hypertension. In: Swales JD (ed): Textbook of Hypertension. Blackwell Scientific Publishing, Oxford 1015–1025
Phillips RA (1993) The cardiologist’s approach to evaluation and management of the patient with essential hypertension. Am Heart J 126:548–666
Puig JG, Ruilope LM (1999) Uric acid as a cardiovascular risk factor in arterial hypertension. J Hypertension 17:869–872
Rosa TT, Palatini P (2000) Clinical value of microalbuminuria in hypertension. J Hypertension 18:645–654
Safar ME, Fröhlich ED (1995) The arterial system in hypertension. A prospective view. Hypertension 26:10–14
Smirk FH (1964) Observations on the mortality of 270 treated and 199 untreated retinal grade I and II hypertensive patients followed in all instances for 5 years. NZ Med J 63:413–443
The Joint Committee on Detection, Evaluation, and Treatment of High Blood Pressure (1997) The sixth report of the Joint Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 157:2443–2446
Ward HJ (1998) Uric acid as an independent risk factor in the treatmemt of hypertension. Lancet 352:670–671
Zanchetti A, Sleight P, Birkenhäger WH (1993) Evaluation of organ damage in hypertension. J Hypertension 11:875–882
Zanchetti A (1999) Carotid artery wall alterations as intermediate endpoints. Clin Exper Hypertension 21(5, 6):595–607
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2001 Steinkopff Verlag Darmstadt
About this chapter
Cite this chapter
Stimpel, M. (2001). Basisdiagnostik bei gesicherter arterieller Hypertonie: Differentialdiagnose und Ermittlung des kardiovaskulären Gesamtrisikos. In: Arterielle Hypertonie. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57617-1_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-57617-1_7
Publisher Name: Steinkopff, Heidelberg
Print ISBN: 978-3-642-63309-6
Online ISBN: 978-3-642-57617-1
eBook Packages: Springer Book Archive